These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7729635)

  • 21. Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations.
    De Vos M; Verdievel H; Schoonjans R; Praet M; Bogaert M; Barbier F
    Gut; 1992 Oct; 33(10):1338-42. PubMed ID: 1446856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Aminosalicylic acid derivatives. Clinical and pharmaceutical evaluation.
    Christensen LA; Jacobsen BA
    Neth J Med; 1989 Jun; 35 Suppl 1():S3-10. PubMed ID: 2702310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption of oral mesalazine-containing preparations and the influence of famotidine on the absorption.
    Wiltink EH; Mulder CJ; Stolk LM; Rietbroek R; Verbeek C; Tytgat GN
    Scand J Gastroenterol; 1990 Jun; 25(6):579-84. PubMed ID: 2359989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bioavailability of 5-aminosalicylic acid from a controlled release preparation and an azo-bond preparation.
    Christensen LA; Fallingborg J; Jacobsen BA; Abildgaard K; Rasmussen HH; Hansen SH; Rasmussen SN
    Aliment Pharmacol Ther; 1994 Jun; 8(3):289-94. PubMed ID: 7918923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release.
    Foppoli A; Maroni A; Moutaharrik S; Melocchi A; Zema L; Palugan L; Cerea M; Gazzaniga A
    Int J Pharm; 2019 Dec; 572():118723. PubMed ID: 31628978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
    Singleton JW; Hanauer SB; Gitnick GL; Peppercorn MA; Robinson MG; Wruble LD; Krawitt EL
    Gastroenterology; 1993 May; 104(5):1293-301. PubMed ID: 8482443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of mesalazine microgranules on experimental colitis].
    Nakamaru K; Sugai T; Hongyo T; Sato M; Taniguchi S; Tanaka Y; Kawase S
    Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):303-11. PubMed ID: 7959421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine.
    Swift GL; Mills CM; Rhodes J; Evans BK; Bennett A; Tavares IA
    Aliment Pharmacol Ther; 1992 Apr; 6(2):259-66. PubMed ID: 1350926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal metabolism and transport of 5-aminosalicylate.
    Zhou SY; Fleisher D; Pao LH; Li C; Winward B; Zimmermann EM
    Drug Metab Dispos; 1999 Apr; 27(4):479-85. PubMed ID: 10101143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distal ileum and colon: targeted sites for 5-ASA release.
    Devane J; Mulligan S; Martin M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():300-3. PubMed ID: 1820897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of olsalazine and mesalazine on intraluminal pH of the duodenum and proximal jejunum in healthy humans.
    Fallingborg J; Christensen LA; Jacobsen BA; Ingeman-Nielsen M; Rasmussen HH; Abildgaard K; Rasmussen SN
    Scand J Gastroenterol; 1994 Jun; 29(6):498-500. PubMed ID: 8079106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability.
    Yu DK; Elvin AT; Morrill B; Eichmeier LS; Lanman RC; Lanman MB; Giesing DH
    Clin Pharmacol Ther; 1990 Jul; 48(1):26-33. PubMed ID: 2369807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A; Griga T; May B
    Hepatogastroenterology; 1999; 46(30):3124-35. PubMed ID: 10626173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children.
    Christensen LA; Fallingborg J; Jacobsen BA; Abildgaard K; Rasmussen HH; Rasmussen SN; Hansen SH
    Dig Dis Sci; 1993 Oct; 38(10):1831-6. PubMed ID: 8104772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocautery-induced localized colonic injury elicits increased levels of pro-inflammatory cytokines in small bowel and decreases jejunal alanine absorption.
    Barada K; Mourad FH; Noutsi B; Saadé NE
    Cytokine; 2015 Jan; 71(1):109-18. PubMed ID: 25277469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of iron absorption by in situ ligated small intestinal loops of broilers involved in iron transporters.
    Zhang LY; Liao XD; Zhang LY; Lu L; Luo XG
    J Anim Sci; 2016 Dec; 94(12):5219-5229. PubMed ID: 28046154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Gendre JP; Mary JY; Florent C; Modigliani R; Colombel JF; Soulé JC; Galmiche JP; Lerebours E; Descos L; Viteau JM
    Gastroenterology; 1993 Feb; 104(2):435-9. PubMed ID: 8425685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.